Mstarin™ is a quality assured generic of Rydapt® which is used to treat newly diagnosed acute myeloid leukemia (AML) in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation in adult patients who are FLT3 mutation-positive. It’s also used to treat mast cell leukemia (MCL), aggressive systemic mastocytosis (ASM), and systemic mastocytosis with associated hematological neoplasm (SM-AHN).
Midostaurin – Mstarin 25 Mg
Package Size : 28 Capsules
Active Ingredients : Midostaurin 25 MG
Produced by BDR Pharmaceuticals Ltd®